Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Red Dragon who wrote (804)	1/6/1998 9:46:00 AM
From: MCorbley	Read Replies (1) of 1115

The suggestion that Lidakol and/or placebo has been ineffective is simply wrong. In both the 1996 phase III study and the study in Belgium/Holland, there was a sizable group of patients who applied Lidaol or placebo in "late stage"--that is, 1 to 2 days after a cold sore episode began. Late stage application of Likdaol or late-stage application of placebo always produced healing times in the range of 7 to 10 days. These were always indistinguishable from untreated cases and always significantly longer than cases where application of the cream began immediately. Several people have mentioned the 1996 results recently, so I will copy that press release into the post following this one. Note that in that study, the "untreated" data were taken from the same patients who participated in the clinical trial. The results of the Belgium/Holland study can be found in a university science library: Acta Derm Venereol (Stockholm) 1996; volume 76, pp. 479-481.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next